{"substancia": "ELOTUZUMABE", "lista": "20261009", "publicado_em": "09/10/2026 12:43:03", "pagina": "https://anvisa.feeds.abelhaninja.de/cmed/substancia/elotuzumabe.html", "feed": "https://anvisa.feeds.abelhaninja.de/cmed/substancia/elotuzumabe.xml", "mudancas": [], "apresentacoes": [{"ggrem": "505118040022902", "registro": "1018004090010", "produto": "EMPLICITI", "apresentacao": "300 MG PO LIOF SOL INJ CT 1 FA VD TRANS", "substancia": "ELOTUZUMABE", "cnpj": "56998982000107", "laboratorio": "BRISTOL-MYERS SQUIBB FARMACÊUTICA LTDA", "tipo_produto": "Biológico", "regime_preco": "Regulado", "tarja": "- (*)", "pf_0": 761116, "pmc_0": null, "pmvg_0": 610491, "restricao_hospitalar": "S", "cap": "N"}, {"ggrem": "505118040023002", "registro": "1018004090029", "produto": "EMPLICITI", "apresentacao": "400 MG PO LIOF SOL INJ CT 1 FA VD TRANS", "substancia": "ELOTUZUMABE", "cnpj": "56998982000107", "laboratorio": "BRISTOL-MYERS SQUIBB FARMACÊUTICA LTDA", "tipo_produto": "Biológico", "regime_preco": "Regulado", "tarja": "- (*)", "pf_0": 1014819, "pmc_0": null, "pmvg_0": 813986, "restricao_hospitalar": "S", "cap": "N"}]}